美國AI服務商Palantir(PLTR.US)連跌五日 自歷史高位累跌近17%
為美國國防部提供大數據分析的美國人工智能服務商Palantir(PLTR.US)股價連跌五個交易日,昨日(19日)跌逾9.3%報157.75美元,市後交易再跌2.7%。該股上周二(12日)創下190美元歷史高位,昨日收市價較歷史高位累跌近17%。
公司早前公布亮麗業績,季度收入首度突破10億美元,推動股價破頂。該股為標普500指數成分股中今年升幅最大股份,目前股價仍較去年底升逾倍,受惠人工智能熱潮及從政府取得合約。該股市值升至美國科技股前十,亦成為美國二十大市值股份之一。該股預測市盈率超過200倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.